MEDRx USA, Inc.

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 2 drugs with upcoming expirations

Activity

Key Events

Sep 24, 2025FDAXylocaine — BONDLIDO

Jun 27, 2025FDAXylocaine — LIGNOSPAN FORTE

Jun 27, 2025FDAXylocaine — LIGNOSPAN STANDARD

Oct 30, 2024FDAXylocaine — XYLOCAINE W/ EPINEPHRINE, XYLOCAINE

Jun 8, 2021FDAXylocaine — LIGNOSPAN FORTE

Jun 8, 2021FDAXylocaine — LIGNOSPAN STANDARD

Nov 2, 2018FDAXylocaine — LIGNOSPAN FORTE

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

5 patent groups across drugs · Source: FDA Orange Book

DrugExpires

XylocaineJul 24, 2026 XylocaineNov 10, 2028 XylocaineOct 22, 2029 Xylocaine8 patentsMay 10, 2031 Xylocaine2 patentsApr 27, 2035

Regulatory

Regulatory Timeline

20132 events

FDADec 26

Xylocaine — XYLOCAINE W/ EPINEPHRINE, XYLOCAINE

Application NDA006488

FDAOct 29

Xylocaine — XYLOCAINE W/ EPINEPHRINE, XYLOCAINE

Application NDA006488

20151 event

FDAMar 3

Xylocaine — XYLOCAINE W/ EPINEPHRINE, XYLOCAINE

Application NDA006488

20161 event

FDAMar 17

Xylocaine — XYLOCAINE W/ EPINEPHRINE, XYLOCAINE

Application NDA006488

20174 events

FDADec 22

Xylocaine — XYLOCAINE W/ EPINEPHRINE, XYLOCAINE

Application NDA006488

FDADec 22

Xylocaine — XYLOCAINE W/ EPINEPHRINE, XYLOCAINE

Application NDA006488

FDAJul 28

Xylocaine — LIGNOSPAN STANDARD

Application ANDA088390

FDAJul 28

Xylocaine — LIGNOSPAN FORTE

Application ANDA088389

20185 events

FDANov 2

Xylocaine — LIGNOSPAN FORTE

Application ANDA088389

FDANov 2

Xylocaine — LIGNOSPAN STANDARD

Application ANDA088390

FDANov 2

Xylocaine — XYLOCAINE W/ EPINEPHRINE, XYLOCAINE

Application NDA006488

FDAFeb 28

Xylocaine — ZTLIDO

Application NDA207962 (NDA)

FDAFeb 28

Xylocaine — ZTLIDO

Application NDA207962 (NDA)

20212 events

FDAJun 8

Xylocaine — LIGNOSPAN FORTE

Application ANDA088389

FDAJun 8

Xylocaine — LIGNOSPAN STANDARD

Application ANDA088390

20241 event

FDAOct 30

Xylocaine — XYLOCAINE W/ EPINEPHRINE, XYLOCAINE

Application NDA006488

20254 events

FDASep 24

Xylocaine — BONDLIDO

Application NDA215029 (NDA)

FDASep 24

Xylocaine — BONDLIDO

Application NDA215029 (NDA)

FDAJun 27

Xylocaine — LIGNOSPAN FORTE

Application ANDA088389

FDAJun 27

Xylocaine — LIGNOSPAN STANDARD

Application ANDA088390

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)